Showing results (11-20 of 71) with videos related to

Sort By:
Pageof 8
Current Oncology Reports|October 3, 2024
Uterine-Conserving Treatment Options for Atypical Endometrial Hyperplasia and Early Endometrial CancerNaomi N Adjei, Mikayla Borthwick Bowen, Roni Nitecki Wilke, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|January 6, 2026
Barriers and interventions to improve the uptake of cancer risk management strategies in hereditary cancer syndromes: a narrative reviewIsabel Beshar, Nuria Agusti, Karla Barajas, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|January 9, 2020
Clinical trial participation and aggressive care at the end of life in patients with ovarian cancerRoni Nitecki, Alexandra S Bercow, Allison A Gockley, et al.
American Journal of Obstetrics and Gynecology|October 1, 2021
Catastrophic health expenditures, insurance churn, and nonemployment among gynecologic cancer patients in the United StatesBenjamin B Albright, Roni Nitecki, Fumiko Chino, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|July 22, 2020
Laparoscopic cytoreduction After Neoadjuvant ChEmotherapy (LANCE)Roni Nitecki, Jose Alejandro Rauh-Hain, Alexander Melamed, et al.
Gynecologic Oncology|February 11, 2020
Effectiveness and toxicity of second-line actinomycin D in patients with methotrexate-resistant postmolar low-risk gestational trophoblastic neoplasiaIzildinha Maestá, Roni Nitecki, Cecilia Canedo Freitas Desmarais, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|November 4, 2024
Oncologic outcomes of incidental serous tubal intraepithelial carcinoma and associated high-grade serous carcinoma in high-risk patients undergoing risk-reducing surgeryEliane Aoun, Barrett Lawson, Chika Awujo, et al.
Gynecologic Oncology|November 3, 2017
Effectiveness and toxicity of first-line methotrexate chemotherapy in low-risk postmolar gestational trophoblastic neoplasia: The New England Trophoblastic Disease Center experienceIzildinha Maestá, Roni Nitecki, Neil S Horowitz, et al.
Gynecologic Oncology|November 13, 2020
Employment disruption following the diagnosis of endometrial cancerRoni Nitecki, Shuangshuang Fu, Carolyn Lefkowits, et al.
Gynecologic Oncology|April 19, 2021
Timing of surgery in patients with partial response or stable disease after neoadjuvant chemotherapy for advanced ovarian cancerRoni Nitecki, Nicole D Fleming, Bryan M Fellman, et al.
Pageof 8